Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PEN

PEN - Penumbra Inc Stock Price, Fair Value and News

$359.20-0.20 (-0.06%)
Market Closed

37/100

PEN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

37/100

PEN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$287.41

Target 3M

$334.11

Target 6M

$310.76

PEN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PEN Price Action

Last 7 days

0.4%

Last 30 days

14.1%

Last 90 days

55.1%

Trailing 12 Months

32.6%

PEN RSI Chart

PEN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PEN Valuation

Market Cap

14.1B

Price/Earnings (Trailing)

85.76

Price/Sales (Trailing)

10.55

EV/EBITDA

67.64

Price/Free Cashflow

92.17

PEN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$287.41

Target 3M

$334.11

Target 6M

$310.76

PEN Fundamentals

PEN Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

17.82%

Rev. Growth (Qtr)

4.49%

PEN Earnings

Earnings (TTM)

164.0M

Earnings Growth (Yr)

55.28%

Earnings Growth (Qtr)

1.28%

PEN Profitability

Operating Margin

66.80%

EBT Margin

13.93%

Return on Equity

12.07%

Return on Assets

9.4%

Free Cashflow Yield

1.08%

PEN Investor Care

Shares Dilution (1Y)

2.04%

Diluted EPS (TTM)

4.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.2B1.3B1.3B0
20241.1B1.1B1.2B1.2B
2023884.6M937.8M995.1M1.1B
2022782.3M806.4M829.9M847.1M
2021592.3M671.4M710.5M747.6M
2020556.3M527.2M538.8M560.4M
2019470.7M495.2M522.9M547.4M
2018363.3M392.3M420.2M444.9M
2017278.6M294.1M310.8M333.8M
2016205.1M227.9M244.6M263.3M
2015138.3M149.1M167.1M186.1M
201498.0M107.2M116.3M125.5M
201300088.8M
Get all data in R, Python etc through our Historical Stock Data APIs

About Penumbra Inc

PEN
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
 CEO
 WEBSITEpenumbrainc.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES3900

Penumbra Inc Frequently Asked Questions

PEN is the stock ticker symbol of Penumbra Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Penumbra Inc is 14.07 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PEN's fair value in chart for subscribers.

The fair value guage provides a quick view whether PEN is over valued or under valued. Whether Penumbra Inc is cheap or expensive depends on the assumptions which impact Penumbra Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PEN.

As of Wed Jan 28 2026, PEN's PE ratio (Price to Earnings) is 85.76 and Price to Sales (PS) ratio is 10.55. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PEN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Penumbra Inc has provided 0.237 (multiply by 100 for percentage) rate of return.